Erin Wright
Stock Analyst at Morgan Stanley
(3.00)
# 1,340
Out of 5,138 analysts
246
Total ratings
87.5%
Success rate
36.77%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Maintains: Overweight | $35 → $38 | $35.79 | +6.17% | 2 | Jan 13, 2026 | |
| HUM Humana | Maintains: Equal-Weight | $277 → $262 | $268.00 | -2.24% | 5 | Dec 18, 2025 | |
| ELV Elevance Health | Maintains: Equal-Weight | $359 → $352 | $367.06 | -4.10% | 5 | Dec 18, 2025 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $18 → $22 | $24.16 | -8.94% | 12 | Dec 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $89 → $93 | $80.09 | +16.12% | 7 | Dec 10, 2025 | |
| ZTS Zoetis | Maintains: Overweight | $211 → $175 | $123.24 | +42.00% | 8 | Nov 10, 2025 | |
| MCK McKesson | Maintains: Overweight | $857 → $916 | $821.84 | +11.46% | 10 | Nov 6, 2025 | |
| HSIC Henry Schein | Maintains: Underweight | $55 → $58 | $77.73 | -25.38% | 5 | Nov 5, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $765 → $805 | $686.02 | +17.34% | 19 | Nov 4, 2025 | |
| ALGN Align Technology | Maintains: Equal-Weight | $142 → $154 | $165.55 | -6.98% | 25 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $163 → $204 | $191.27 | +6.66% | 3 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $32 | $38.73 | -17.38% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $128 → $140 | $138.47 | +1.10% | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $24.34 | -30.16% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $313 → $330 | $350.67 | -5.89% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $181 → $190 | $210.37 | -9.68% | 12 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $41.08 | -36.71% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $271.24 | +43.78% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $3.29 | -2.74% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $12.05 | +90.87% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $188.95 | -8.97% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $338.43 | +73.45% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $271.31 | +10.57% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $11.85 | +254.43% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $234.33 | +22.90% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $218.19 | +61.33% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.75 | +1,073.33% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $602.40 | -69.95% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $65.88 | -74.20% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $32.97 | +267.00% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $619.01 | -6.30% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $9.49 | +268.81% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $176.57 | +16.10% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $27.69 | -60.27% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $233.69 | -32.82% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $576.06 | -46.53% | 1 | Oct 25, 2017 |
Option Care Health
Jan 13, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $35.79
Upside: +6.17%
Humana
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $277 → $262
Current: $268.00
Upside: -2.24%
Elevance Health
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $359 → $352
Current: $367.06
Upside: -4.10%
Elanco Animal Health
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $18 → $22
Current: $24.16
Upside: -8.94%
CVS Health
Dec 10, 2025
Maintains: Overweight
Price Target: $89 → $93
Current: $80.09
Upside: +16.12%
Zoetis
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $123.24
Upside: +42.00%
McKesson
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $821.84
Upside: +11.46%
Henry Schein
Nov 5, 2025
Maintains: Underweight
Price Target: $55 → $58
Current: $77.73
Upside: -25.38%
IDEXX Laboratories
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $686.02
Upside: +17.34%
Align Technology
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $142 → $154
Current: $165.55
Upside: -6.98%
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $163 → $204
Current: $191.27
Upside: +6.66%
Oct 14, 2025
Maintains: Overweight
Price Target: $25 → $32
Current: $38.73
Upside: -17.38%
Oct 3, 2025
Maintains: Equal-Weight
Price Target: $128 → $140
Current: $138.47
Upside: +1.10%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $24.34
Upside: -30.16%
Jul 16, 2025
Maintains: Equal-Weight
Price Target: $313 → $330
Current: $350.67
Upside: -5.89%
Jul 16, 2025
Maintains: Overweight
Price Target: $181 → $190
Current: $210.37
Upside: -9.68%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $41.08
Upside: -36.71%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $271.24
Upside: +43.78%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $3.29
Upside: -2.74%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $12.05
Upside: +90.87%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $188.95
Upside: -8.97%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $338.43
Upside: +73.45%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $271.31
Upside: +10.57%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $11.85
Upside: +254.43%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $234.33
Upside: +22.90%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $218.19
Upside: +61.33%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.75
Upside: +1,073.33%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $602.40
Upside: -69.95%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $65.88
Upside: -74.20%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $32.97
Upside: +267.00%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $619.01
Upside: -6.30%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $9.49
Upside: +268.81%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $176.57
Upside: +16.10%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $27.69
Upside: -60.27%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $233.69
Upside: -32.82%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $576.06
Upside: -46.53%